Special Edition #AIEye: How #ArtificialIntelligence ( #AI)
is Tracking, Modeling and Providing Medical Info #Coronavirus (OTC: $GTCH)
(NASDAQ: $NVDA) (NYSE: $IBM) (NASDAQ: $MSFT)
Point Roberts WA, Vancouver BC – March 24,
2020 – Investorideas.com (www.investorideas.com), a global investor news source
covering Artificial Intelligence (AI)
brings you today’s edition of The AI Eye which looks at how AI is
playing a leading role in tracking, modeling and providing general medical
information as well as information on the coronavirus, featuring technology
company GBT Technologies Inc. (OTCPINK:GTCH).
Read
this news featuring GTCH in full at https://www.investorideas.com/news/2020/artificial-intelligence/03241AIEye-GTCH-NVDA-IBM-MSFT.asp
Taiwan, one of the countries
that got it right according to a recent
article by Stanford Health
Policy, used AI, big data and analytics to track and manage the disease in
combination with proactive testing.
“Taiwan’s government learned
from its 2003 SARS experience and established a public health response
mechanism for enabling rapid actions for the next crisis.”
ABC news reported, “Audrey Tang, Taiwan's digital minister and the youngest
minister without portfolio to hold office, utilized artificial intelligence to
harness data and created real-time digital updates to alert citizens of risky
areas to avoid and a live map of local supplies of face masks.”
Currently (as of March 22, 2020)
Taiwan has 169 cases, 2 deaths and 28 recovered.
The US is now following a similar
path, with tech leaders and government turning to AI for solutions, with
initiatives including the COVID-19
Open Research Dataset (CORD-19).
Smaller companies like GBT Technologies, Inc.
(OTCPINK:GTCH) an emerging technology company
focusing on artificial intelligence innovations and chip design was directing
research and development resources into healthcare and medicine prior to the
pandemic, using the company’s Avant! AI licensed technology (https://www.avant-ai.net)
and introducing as “derivative” a new tool - https://www.hmd.care
as beta version.
In a previous interview with Investor Ideas, CTO Danny Rittman explained how Avant!, powered by cooperation with Costa Rica developers works: "Our goal is to implement a fundamental part of human intelligence called relational reasoning, which is planned to enable Avant! to acquire expertise on its own by understanding object's relations. Avant! will include an advanced artificial neural network (ANN) capable of pattern recognition and reasoning about those patterns which is very similar to the human brain. Rather than operating on pre-set rules, the system will learn image's patterns by tweaking the relations between objects, analyzing connections, and building hypotheses about how they relate to each other. This capability will be used for Avant! imaging system for upcoming implementation in the medical field. We are creating an interactive and intuitive intelligent system that performs complex computation over discrete entities and the relations between them. Our goal is to provide Avant! a broad range of advantages and capabilities when it comes to intelligent imaging, especially in the medical domain."
Building on its healthcare applications, a
new development from the team at Costa Rica is the launch of Hippocrates – its
new AI-based medical advisor (https://www.hmd.care).
Hippocrates health system is an AI-based medical advisor. Users may provide
symptoms, ask medical questions and describe conditions in order to get
diagnosis advice including known medications and treatments. This means a
reliable, simple and fast medical assistance experiences for people around the
world. It provides the essential capabilities necessary to advise patients
about medical symptoms and conditions based on data and analytics taken from
The National Center for Biotechnology, CDC and other accredited resources. The
system is now in testing phase and has been trained to support basic health
information. The team will evaluate the system for the next few months,
targeting it to ultimately becoming an expert in a specific area, for example,
respiratory or cardiovascular diseases. The service is available for adults
(18+) under a disclaimer and is not intended to replace a human physician.
According to IBM ( NYSE:
IBM), “Watson Health unit is working directly with health organizations
around the world to better understand the nature of COVID-19. The IBM
Clinical Development system has been made available without charge to national
health agencies to reduce the time and cost of clinical trials by providing
data and analysis from web-enabled devices.”
“And our cognitive Operational Risk Insight tool has been made available to not-for-profit organizations,
charged with information about the virus spread.”
IBM also reported,
“US Department of Energy’s Oak Ridge National Laboratory (ORNL) has deployed the world’s most powerful and
smartest supercomputer, IBM built Summit, in the fight against COVID-19.”
(NASDAQ:
NVDA) reported, “At the epicenter of the
Coronavirus in Wuhan China, a team of physicians at the Zhongnan Hospital are
using GPU-accelerated AI software to detect visual signs of the coronavirus
(Covid 19).”
“Physicians there say the AI-based
software, which relies on NVIDIA GPUs for both training and inference, has
helped overworked staff screen patients and prioritize those likely to have the
virus.”
“The software, developed by Beijing-based
startup Infervision, a member of the NVIDIA Inception, NVIDIA’s startup
accelerator program, can identify typical signs or partial signs of Covid 19
infection. To do this, Infervision’s software detects signs of pneumonia caused
by the virus.”
“Once the outbreak began, the company
quickly fine-tuned their existing pneumonia models to look more closely at
coronavirus pneumonia.”
The White House, realizing how AI can play
an integral role in finding solutions, issued a press
release on March 16th, ‘Call to Action to the Tech Community on New
Machine Readable COVID-19 Dataset’.
From the news – “Today,
researchers and leaders from the Allen Institute for AI, Chan Zuckerberg
Initiative (CZI), Georgetown University’s Center for Security and Emerging
Technology (CSET), Microsoft (NASDAQ:
MSFT) and the National
Library of Medicine (NLM) at the National Institutes of Health released
the ‘COVID-19 Open Research Dataset (CORD-19’) of scholarly
literature about COVID-19, SARS-CoV-2, and the Coronavirus group.”
“Now, the White
House joins these institutions in issuing a call to action to the Nation’s
artificial intelligence experts to develop new text and data mining techniques
that can help the science community answer high-priority scientific questions
related to COVID-19.”
“The collection was constructed via a unique collaboration
between Microsoft, NLM, CZI, and the Allen Institute for AI, coordinated by
Georgetown University. Microsoft’s web-scale literature curation tools were
used to identify and bring together worldwide scientific efforts and results,
CZI provided access to pre-publication content, NLM provided access to
literature content, and the Allen AI team transformed the content into
machine-readable form, making the corpus ready.”
As the global race continues to track, manage and find solutions for the
coronavirus, AI can move rapidly, analyze data, map and provide medical
information and updates to the world as vaccines are being developed. AI is currently
on a path to replace dogs as man’s best friend; at least for the short term.
To get current numbers by country on the
Coronavirus visit:
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE)
For
a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member
About Investorideas.com -
News that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye Podcast
and column covering developments in AI.
The
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com,
iHeartRadio and Google Play Music.
Visit
the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced
news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. Disclosure: GTCH is a paid
monthly featured company for news and social media on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.aspLearn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The
AI Eye- Watching stock news, deal tracker and
advancements in artificial intelligence is an original content brand of
Investorideas.com
Contact
Investorideas.com
800 665 0411
 |
 |
